- Home
- KPTI vs CHPT Comparison
KPTI vs CHPT Comparison
Compare KPTI & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPTI | CHPT |
|---|---|---|
| Founded | 2008 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.8M | 190.2M |
| IPO Year | 2013 | 2019 |
Fundamental Metrics
Financial Performance| Metric | KPTI | CHPT |
|---|---|---|
| Price | $9.02 | $7.54 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 9 |
| Target Price | ★ $16.00 | $9.25 |
| AVG Volume (30 Days) | 434.6K | ★ 483.1K |
| Earning Date | 05-04-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $146,067,000.00 | ★ $411,224,000.00 |
| Revenue This Year | N/A | $4.18 |
| Revenue Next Year | $22.36 | $16.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $3.65 | $0.58 |
| 52 Week High | $10.99 | $12.62 |
Technical Indicators
Market Signals| Indicator | KPTI | CHPT |
|---|---|---|
| Relative Strength Index (RSI) | 58.40 | 64.56 |
| Support Level | $5.43 | $7.30 |
| Resistance Level | $9.32 | $12.62 |
| Average True Range (ATR) | 0.81 | 0.51 |
| MACD | 0.07 | 0.12 |
| Stochastic Oscillator | 66.13 | 77.40 |
Price Performance
Historical ComparisonAbout KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable charging systems owners, charge point operators, to manage their Networked Charging Systems, and to enable drivers to locate, reserve and authenticate Networked Charging Systems and to transact EV charging sessions on those systems. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. The company derives the majority of its revenue from the United States.